Slovenia - Tiếng Slovenia - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

ebewe pharma - metotreksat - koncentrat za raztopino za infundiranje - metotreksat 100 mg / 1 ml - metotreksat

Slovenia - Tiếng Slovenia - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

ebewe pharma - metotreksat - koncentrat za raztopino za infundiranje - metotreksat 100 mg / 1 ml - metotreksat

Liên Minh Châu Âu - Tiếng Slovenia - EMA (European Medicines Agency)

glaxo group limited  - retigabin - epilepsija - antiepileptics, - zdravilo trobalt je indicirano kot dodatno zdravljenje epileptičnih napadov z odpornimi proti drogam s sekundarno generalizacijo ali brez nje pri bolnikih, starih 18 let ali več, pri katerih so se druge primerne kombinacije zdravil izkazale za neustrezne ali niso bile tolerirane.

Liên Minh Châu Âu - Tiếng Slovenia - EMA (European Medicines Agency)

bial - portela ca, s.a. - eslikarbazepin acetat - epilepsija - antiepileptics, - zdravilo exalief je indicirano kot dodatno zdravljenje pri odraslih z epileptičnim napadom s sekundarno generalizacijo ali brez nje.

Liên Minh Châu Âu - Tiếng Slovenia - EMA (European Medicines Agency)

ucb pharma sa - brivaracetam - epilepsija - antiepileptics, - briviact je indiciran kot dodatna terapija pri zdravljenju napadov s parcialnim nastopom s sekundarno generalizacijo ali brez nje pri odraslih in mladostnikih, starih od 16 let, z epilepsijo.

Liên Minh Châu Âu - Tiếng Slovenia - EMA (European Medicines Agency)

eisai gmbh - perampanel - epilepsije, delno - antiepileptics, druge antiepileptics - zdravilo fycompa je indicirano za dodatno zdravljenje epileptičnih napadov z ali brez sekundarnih generaliziranih napadov pri odraslih in mladostnikih, starih od 12 let, z epilepsijo. fycompa je primerna za adjunctive zdravljenju primarne splošni tonik-clonic zasegov v izobraževanju odraslih in mladostnikov bolnikih od 12. leta starosti z idiopatsko splošnih epilepsijo.

Liên Minh Châu Âu - Tiếng Slovenia - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - idecabtagene vicleucel - multiple myeloma; neoplasms; cancer; neoplasms, plasma cell; hemostatic disorders; vascular diseases; cardiovascular diseases; paraproteinemias; blood protein disorders; hematologic diseases; hemic and lymphatic diseases; hemorrhagic disorders; infectious mononucleosis; lymphoproliferative disorders; immunoproliferative disorders; immune system diseases - antineoplastična sredstva - abecma is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti cd38 antibody and have demonstrated disease progression on the last therapy.

Liên Minh Châu Âu - Tiếng Slovenia - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - antineoplastična sredstva - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.

Liên Minh Châu Âu - Tiếng Slovenia - EMA (European Medicines Agency)

janssen-cilag international n.v. - talquetamab - multiple myeloma - antineoplastična sredstva - talvey is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least 3 prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti cd38 antibody and have demonstrated disease progression on the last therapy.

Liên Minh Châu Âu - Tiếng Slovenia - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - epcoritamab - lymphoma, large b-cell, diffuse - antineoplastična sredstva - tepkinly as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) after two or more lines of systemic therapy.